Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Clinical Breast Cancer
|
June 14, 2011
Isolated sternal involvement in breast cancer: is it truly stage IV disease?
Porselvi Chockalingam, Alan B Astrow, Paula Klein, et al.
Gynecologic Oncology
|
November 5, 1997
High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up
F Shapiro, J Schneider, M Markman, et al.
Psychiatric Services (Washington, D.C.)
|
December 1, 2007
"We never used to do things this way": behavioral health care reform in New Mexico
Cathleen E Willging, Leslie Tremaine, Richard L Hough, et al.
American Journal of Obstetrics and Gynecology
|
March 1, 1989
Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
S C Rubin, W J Hoskins, T B Hakes, et al.
Bulletin of the New York Academy of Medicine
|
January 1, 1976
The professional responsibility for the quality of health care. A discussion of methods. Panel discussion
C Rosenberg, A Donabedian, S M Greenberg, et al.
Neurology
|
February 10, 2010
Intracerebral and subarachnoid hemorrhage in patients with cancer
B B Navi, J S Reichman, D Berlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1993
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
B S Reichman, A D Seidman, J P Crown, et al.
Annals of the New York Academy of Sciences
|
November 30, 1993
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report
B S Reichman, A D Seidman, J P Crown, et al.
Seminars in Oncology
|
August 1, 1993
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer
A D Seidman, L Norton, B S Reichman, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1993
Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report
A D Seidman, B S Reichman, J P Crown, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Clinical Breast Cancer
|
June 14, 2011
Isolated sternal involvement in breast cancer: is it truly stage IV disease?
Porselvi Chockalingam, Alan B Astrow, Paula Klein, et al.
Gynecologic Oncology
|
November 5, 1997
High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up
F Shapiro, J Schneider, M Markman, et al.
Psychiatric Services (Washington, D.C.)
|
December 1, 2007
"We never used to do things this way": behavioral health care reform in New Mexico
Cathleen E Willging, Leslie Tremaine, Richard L Hough, et al.
American Journal of Obstetrics and Gynecology
|
March 1, 1989
Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
S C Rubin, W J Hoskins, T B Hakes, et al.
Bulletin of the New York Academy of Medicine
|
January 1, 1976
The professional responsibility for the quality of health care. A discussion of methods. Panel discussion
C Rosenberg, A Donabedian, S M Greenberg, et al.
Neurology
|
February 10, 2010
Intracerebral and subarachnoid hemorrhage in patients with cancer
B B Navi, J S Reichman, D Berlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1993
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
B S Reichman, A D Seidman, J P Crown, et al.
Annals of the New York Academy of Sciences
|
November 30, 1993
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report
B S Reichman, A D Seidman, J P Crown, et al.
Seminars in Oncology
|
August 1, 1993
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer
A D Seidman, L Norton, B S Reichman, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1993
Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report
A D Seidman, B S Reichman, J P Crown, et al.
Page
of 5